Denmark· DK-28101591194
Cytarabine "Pfizer"
A cytarabine product containing cytarabin, registered in Denmark by Pfizer ApS. The same ATC class is registered in 16 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Cytarabine is registered in 16 of 19 countries.
Countries holding a registration under ATC L01BC01 (cytarabine), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 9 of them publish a price we can compare per daily dose
Cytarabine · ATC L01BC01
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- CYTARABIN
- Manufacturer
- Pfizer ApS
- Country
- Denmark (DK)
- ATC code
- L01BC01
- ATC class
- Cytarabine
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28101591194
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
415 interactions on record for cytarabine.
Graded by severity as the source publishes them — 35 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cytarabine · interactions on record
415 records
- 35 severe
- 113 moderate
- 16 minor
- 251 info
Most severe, free to view
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- CladribineL01BB04severe
- PexidartinibL01EX15severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under L01BC01
Cytarabine, as other registers publish it.
- PolandAlexanEbewe Pharma Ges.m.b.H Nfg. KG
- PolandAlexanEbewe Pharma Ges.m.b.H Nfg. KG
- CzechiaALEXANEBEWE Pharma Ges.m.b.H Nfg.KG, Unterach
- CzechiaALEXANEBEWE Pharma Ges.m.b.H Nfg.KG, Unterach
- CzechiaALEXANEBEWE Pharma Ges.m.b.H Nfg.KG, Unterach
- GermanyAra-CellStadapharm Gmbh
- FinlandArabineHospira Nordic AB
- FranceARACYTINE 1 g, poudre pour solution pour perfusion (I.V.)PFIZER HOLDING FRANCE
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c6a57450-bfb4-4f95-83a2-1a5c8d300a6f GET /v1/drugs/c6a57450-bfb4-4f95-83a2-1a5c8d300a6f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "injektions-/infusionsvæske, opløsning",
"source": "dkma",
"strength": "20 mg/ml",
"auth_role": "DKMA",
"dk_drugid": "28101591194",
"substance": "CYTARABIN",
"auth_procedure": "National",
"in_medicinpriser": true,
"registration_date_serial": "34836"
}See everything about cytarabine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.